Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer-Reference-Cited by-同舟云学术

Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer

Published:2008-12-03 Issue:24 Volume:51 Page:7933-7943
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chen Ying¹,Foss Catherine A.¹,Byun Youngjoo¹,Nimmagadda Sridhar¹,Pullambhatla Mrudula¹,Fox James J.¹,Castanares Mark¹,Lupold Shawn E.¹,Babich John W.¹,Mease Ronnie C.¹,Pomper Martin G.¹

Affiliation:

1. Russell H. Morgan Department of Radiology and Radiological Sciences, Department of Pharmacology & Molecular Sciences, Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts 02142

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm801055h

Reference53 articles.

1. Cancer Statistics, 2003

2. Proton MR spectroscopy of the prostate

3. Predictive and prognostic value of FDG-PET

4. Nuclear Imaging Probes: from Bench to Bedside

5. Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA-encoded chemical libraries enable the discovery of potent PSMA-ligands with substantially reduced affinity towards the GCPIII anti-target;Chemical Science;2024

2. PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?;Theranostics;2024

3. Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer;Seminars in Nuclear Medicine;2023-09

4. Synthesis and Radiolabeling of Glu-Urea-Lys with ^99mTc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor;Cancer Biotherapy and Radiopharmaceuticals;2023-09-01

5. The development of cyclotron-based radiopharmaceuticals: a comprehensive review of 64Cu and 123I-radiolabeled urea-based small molecule PSMA ligands;Journal of Radioanalytical and Nuclear Chemistry;2023-08-04